Kids’ meals are in vogue, according to Cava CEO Brett Schulman.
The slop bowl chain is seeing an increasing consumer base that he calls “big kids” — adult customers on GLP-1 drugs opting for kids’ portions.
In response to a question during a Tuesday earnings call about how weight-loss drugs were changing consumer behaviors, Schulman said Cava’s offerings were already in line with what GLP-1 Consumers want: “GLPs are shifting folks more to our style of eating.”
“We have seen some of our — we call them big kids — opt into our kids meal a little bit more in recent months from a portion standpoint, but in general we’ve just seen more people…
